Favorable outcome of severe acute hepatitis B in a patient treated with antithrombin III and antiviral therapy

Clin Infect Dis. 2009 Aug 1;49(3):481. doi: 10.1086/600822.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antithrombin III / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Hepatitis B / drug therapy*
  • Humans
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics
  • Middle Aged
  • Point Mutation
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Antithrombin III
  • Methylenetetrahydrofolate Reductase (NADPH2)